Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), used primarily to treat excess abdominal fat in HIV-infected patients with lipodystrophy. Unlike steroids, tesamorelin stimulates the pituitary gland to produce more human growth hormone (HGH), affecting metabolic processes rather than muscle growth.
Tesamorelin is not a steroid; it’s a synthetic peptide hormone acting as a growth hormone-releasing factor analogue, stimulating the pituitary gland to release human growth hormone. Primarily used in treating lipodystrophy in HIV patients, it reduces abdominal fat. Unlike steroids, which are synthetic testosterone derivatives promoting muscle growth, tesamorelin modulates growth hormone levels for specific therapeutic applications in metabolic conditions, differing significantly in pathways and medical uses.
